Therefore, despite the proven clinical benefits of LP, multiple cancer cell phenotypes commonly escape its therapeutic effects through the activation of alternative survival pathways, including HGF/c-Met pathway [20,36,44,45,46,47,48]. The gene discussed is MET; the disease is cancer.